Fortis Healthcare announced strong financial results for the second quarter of FY26. Consolidated revenue increased by 17.3% to ₹2,331 Cr. Operating EBITDA margin improved to 23.9%, and profit after tax rose significantly to ₹329 Cr, representing a 70.3% year-over-year increase. The hospital business and diagnostics divisions both contributed to the positive results.
Financial Performance Highlights
Fortis Healthcare reported robust financial results for Q2 FY26, demonstrating strong growth across its key business segments:
- Consolidated Revenue: Increased by 17.3% year-over-year to ₹2,331 Cr.
- Operating EBITDA Margin: Improved to 23.9% compared to 21.9% in Q2 FY25.
- Profit After Tax (PAT): Rose by 70.3% year-over-year to ₹329 Cr.
Segment Performance
Both the hospital and diagnostics businesses showed strong performance:
- Hospital Business Revenue: Grew by 19.3% to ₹1,974 Cr.
- Hospital EBITDA Margin: 22.9% versus 21.4% in Q2 FY25.
- Diagnostic Business Revenue: Increased by 7.1% to ₹357 Cr (net).
- Diagnostic EBITDA Margin: 29.1%.
Balance Sheet Update
The company’s net debt stood at ₹2,219 Cr as of September 30, 2025, with a net debt to EBITDA ratio of 0.96x.
Operational Updates
Fortis expanded its operational footprint with key developments:
- Entered a 15-year lease for a 200-bedded multi-specialty hospital in Greater Noida.
- Forged an Operations and Management (O&M) agreement for a 550-bedded greenfield super specialty hospital in Lucknow.
Key Performance Indicators (KPIs)
The hospital business demonstrated healthy KPIs:
- Occupancy: 71%
- ARPOB: ₹2.51 Cr per annum.
Specialty Performance
Focus specialties like Oncology and Renal Sciences demonstrated strong growth, increasing by 29% and 22%, respectively.
Source: BSE
